INTRODUCTION
during 1986 were lower (e.g., 19% for meningitis due to S. pneumoniae) (178) (126, 148, 165, 166) .
Animal Models Experimental animal models have been employed extensively during the past 2 decades to increase our understanding of the pathogenesis and pathophysiology of bacterial meningitis (163) . In the most commonly employed infant rat model, animals developed meningitis following intranasal challenge with H. influenzae type b (84) . This model most closely simulates the presumed pathogenesis of H. influenzae meningitis in humans, since there was an initial nasopharyngeal focus followed by bacteremia and an age-dependent susceptibility to meningeal invasion (83) . The incidence of bacterial meningitis, irrespective of rat host age, was directly related to the intensity of bacteremia. Infant rats also developed meningitis after orogastric challenge with Eschenchia coli (82) . The infant rat model of H. influenzae meningitis has been used primarily to study the early pathogenic events of bacterial meningitis. These include the determinants of nasopharyngeal colonization and translocation into the bloodstream, intravascular survival of the organism, bacteremia, and the mechanisms of central nervous system (CNS) invasion. The animal's small size is a disadvantage of the infant rat model because only small samples (7 to 25 RI) of cerebrospinal fluid (CSF) are obtainable from 5-to 10-day-old rats, precluding frequent sampling of CSF. Therefore, this model is less suitable for study of the pathophysiologic consequences of bacterial meningitis, since frequent sampling of CSF is usually required for studying these events. Infant primates have also been used in the study of the pathogenesis of bacterial meningitis. In one study (130) , bacteremia and meningitis developed in 89 and 94% of animals, respectively, following the atraumatic intranasal inoculation of H. influenzae type b. Although this model closely simulates the spectrum of invasive H. influenzae disease seen in humans, it is employed infrequently because of expense.
Experimental models of meningitis in adult rabbits or rats rely on the direct intracisternal inoculation of bacteria for initiation of infection (30, 110) . These animals reliably develop lethal infections with a predictable time course, although the natural bacteremia-meningitis sequence is bypassed, thereby creating an artificial pathogenesis. However, these models have been extremely useful for the study of the pathophysiologic consequences of bacterial meningitis after organisms have reached the subarachnoid space. CSF samples from these adult animals may be obtained often.
The following sections briefly review the pathogenesis and pathophysiology of bacterial meningitis, as depicted in Fig.  1 , emphasizing the relationships between specific bacterial virulence factors and host defense mechanisms that are responsible for clinical expression of disease (126, 165, 166) . New areas of investigation, as suggested by several of the steps depicted in Fig. 1 Many of the major meningeal pathogens possess surface characteristics that enhance mucosal colonization. Fimbriae, or pili, are specific organelles found on many bacteria and often mediate adhesion of bacteria to host cells (10) . The fimbriae of N. meningitidis mediate adherence of the organism to nasopharyngeal epithelial cells ( Fig. 2) (143, 145) . Meningococci, like gonococci, possess fimbriae that differ in their morphologic, antigenic, and binding properties (51) . Fimbriae appear morphologically as aggregated bundles or single filaments. The aggregated bundles are found primarily among disease isolates and exhibit a low degree of adherence to human buccal epithelial cells, whereas the single filaments are found predominantly among colonizing isolates with medium to high adherence characteristics. These (72, 146) , and lack of fimbrial expression impairs the ability of H. influenzae type b to colonize the nasopharynx (177) . However, fimbriae have not been found on H. influenzae type b isolated from the CSF or blood of patients with invasive disease (72, 106) (3, 55, 56, 65) . More recently, hemocin, the bacteriocin produced by H. influenzae, has been shown to be strongly associated with type b encapsulated strains and may play a role in host nasopharyngeal colonization and/or systemic invasion by this organism. After intranasal inoculation of infant rats with an equal mixture of a non-hemocin-producing strain and its hemocin-producing transformant, organisms capable of hemocin production predominated in isolates from both nasopharyngeal and blood cultures (70 (27, 29, 187) . Although the incidence of bacteremia due to type b organisms increases from 63 to 95% in complement-depleted rats, the incidence and severity of meningitis are unaffected.
Activation of the complement system is an essential host defense mechanism in protection against invasive disease by N. meningitidis. Patients with deficiencies in the terminal complement components (C5, C6, C7, C8, and perhaps C9), the so-called membrane attack complex, are particularly prone to infection with neisserial species, including N. meningitidis, though usually with a favorable outcome for the patient when appropriate treatment is instituted (122) . The reasons for the decreased mortality rate in the complement-deficient patients are not clear. It has been suggested that the presence of complement-activating products (i.e., the membrane attack complex), in concert with other mediators, may contribute to the development of multiorgan failure and death. A qualitative relationship exists among the level of circulating meningococcal LPS, a fatal outcome, and the degree of complement activation (19) , indicating that prognosis is worse for patients with intact complement systems.
MENINGEAL INVASION
The mechanisms by which bacterial pathogens gain access to the CNS are largely unknown. One factor may relate to the concentration of organisms in the blood (84) . In the experimental infant rat model, the intranasal inoculation of H. influenzae type b initially produced a low-grade bacteremia (about 102 CFU/ml) and no organisms were present in the CSF (141) . Culture-positive meningitis was observed only after an intense bacteremia (>10W CFU/ml) had been present for at least 6 h (100). Meningitis was also induced in an age-dependent manner, with a higher incidence in 5-dayold than in 20-day-old rats (83) . In the animals that ultimately developed meningitis, sustained bacteremia, as opposed to transient bacteremia, was documented. However, sustained bacteremia is not the only factor responsible for meningeal invasion, because many other organisms (e.g., viridans streptococci) that produce continuous bacteremia during infective endocarditis rarely produce bacterial meningitis. Secondary Bacteremia Following bacterial invasion of the subarachnoid space, a secondary bacteremia may result from the local CNS suppurative process, allowing the meningeal pathogen to continuously enter and leave the CSF compartment under quite dynamic circumstances. In an experimental canine model of pneumococcal meningitis, the early transport of bacteria from CSF to blood was presumed to be transendothelial through arachnoid villi containing pores large enough to accommodate bacteria, which would then enter the superior sagittal sinus and return to the central venous blood (135) . This transport occurred only following active bacterial multiplication in CSF and before the height of the febrile response or CSF pleocytosis. This phenomenon was also observed with H. influenzae type b, inoculation of which into the cisterna magna of experimental animals produced an almost instantaneous bacteremia (140) .
ALTERATIONS OF THE BBB
Bacterial meningitis, like many other disease states, increases the permeability of the blood-brain barrier (BBB). The major sites of the BBB are the arachnoid membrane, choroid plexus epithelium, and cerebral microvascular endothelium. Previous extensive morphologic studies have demonstrated intact arachnoid membranes in animals with bacterial meningitis (176) . Therefore, the increased BBB permeability seen in this disorder must occur at the level of the choroid plexus epithelium, the cerebral microvascular endothelium, or both; the cerebral microvascular endothelium has been the site of intensive study in recent years as a result of techniques for isolation of cerebral microvessels or endothelial cells or both. The features that distinguish cerebral capillaries from other capillaries throughout the body are (i) adjacent endothelial cells fused together by pentalaminar tight junctions (zonulae occludens) that prevent intercellular transport; (ii) rare or absent pinocytotic vesicles; and (iii) abundant mitochondria (18, 49) . Therefore, the increased BBB permeability that occurs during bacterial meningitis at the level of the cerebral capillary endothelial cell may result from separation of intercellular tight junctions, from increased pinocytosis, from both alterations, or by processes as yet unknown.
An adult rat model of bacterial meningitis was used to investigate the propensity for bacterial meningitis to induce functional and morphologic alterations of the BBB (110) . Following the intracisternal inoculation of either E. coli, S. pneumoniae, or H. influenzae into rats, a uniform host response to all three encapsulated pathogens was observed at the level of the cerebral capillary endothelial cell, characterized morphologically by an early and sustained increase in pinocytotic vesicle formation and a progressive increase in separation of intercellular tight junctions from 4 to 18 h postinoculation (Table 1) . These morphologic changes correlated with the functional penetration of albumin across the BBB, with the highest values of albumin entry occurring 18 h after intracisternal inoculation, when both morphologic changes were evident. Following intracisternal inoculation of an unencapsulated strain of H. influenzae (Rd strain), there was an increase in pinocytotic vesicle formation, but separation of intercellular tight junctions did not occur. This discrepancy between encapsulated and unencapsulated strains of H. influenzae likely occurred secondary to the removal of unencapsulated organisms from the CSF by host defense mechanisms, whereas deficient opsonic mechanisms in the CSF (see below) permitted sustained concentrations of the encapsulated strain. Therefore, encapsulation of H. influenzae was not essential for BBB injury but facilitated the progression of such injury by avoidance of host defense mechanisms.
The effect of the host leukocyte response on altered BBB permeability was subsequently examined in the experimental rat model by first rendering the animals leukopenic 4 days following intraperitoneal injection of cyclophosphamide (68) . Functional increases in BBB permeability, assessed by penetration of radioactive albumin from blood to CSF, were observed in both normal and leukopenic rats at 18 h following inoculation of either encapsulated or unencapsulated strains of H. influenzae, but permeability was greater after challenge with the encapsulated strain. Significant increases in BBB permeability occurred in the near absence of leukocytes in CSF late in the disease process, although the presence of leukocytes augmented changes in permeability. At 18 h following inoculation, alterations of BBB permeability correlated with concentrations of bacteria in the CSF.
LPS
Since bacterial capsule was not essential for BBB injury in the experimental rat model of bacterial meningitis and since it was recognized that pneumococcal capsule did not induce inflammation within the subarachnoid space (see below), BBB permeability was examined following intracisternal inoculation of purified H. influenzae type b LPS. After intracisternal inoculation of LPS into rats, the following results were observed (183): (i) dose-dependent increases in BBB permeability from 2 pg to 20 ng, with attenuation in peak response after challenge with 500 ng or 1 ,ug; (ii) time-dependent increases in BBB permeability, with maximal alteration at 4 h and complete reversal at 18 h (Fig. 3) 4 h following intracisternal inoculation, it was suggested that a common host mediator(s) was responsible. Therefore, it was next determined whether specific inflammatory cytokines, which mediate many of the deleterious effects of LPS, also increased permeability (112) . Intracisternal inoculation of human recombinant interleukin-lp (IL-1ip) into rats led to a peak increase in BBB permeability about 3 h after inoculation (Fig. 4) , which is earlier than the peak response observed with LPS (at 4 h). This effect was significantly attenuated by preincubation of the cytokine with a monoclonal antibody to IL-1l3 and was totally abolished in leukopenic animals. Preincubation of IL-1lB with polymyxin B did not alter IL-1,B activity. No permeability changes were observed following intracisternal inoculation of human recombinant tumor necrosis factor alpha (TNF-a) into rats, although rabbit TNF-ot clearly elicits subarachnoid space inflammation following intracistemal inoculation of the homologous species. All available evidence suggests that both cytokines are important and that they act synergistically, since inoculation with submaximal doses of IL-lp plus TNF-a at concentrations that produced no changes individually enhanced BBB permeability.
Localization of BBB Injury
The precise localization of BBB injury in bacterial meningitis was subsequently examined by in situ tracer perfusion VOL. 6, 1993 on (162, 164) . Isolated cerebral microvascular endothelium has been shown to retain many of the characteristics of an intact BBB, including the ability to form intercellular tight junctions in vitro.
Treatment of intact cerebral microvascular endothelial cell monolayers with LPS (0.1 ,ug/ml) in serum-free media led to a statistically significant increase in the percentage of radioactive albumin able to permeate the monolayer (2.2 to 5.6%; P < 0.001) in the absence of host inflammatory cells. This increase in permeability was not associated with cytotoxicity as assessed by release of lactate dehydrogenase into the media. To determine the putative intracellular regulatory mechanisms responsible for this increased ability to permeate monolayers in the in vitro model, the effects of LPS on the formation of various second messenger systems in the cerebral microvascular endothelial cells in response to LPS stimulation were examined (161) . Production of both cyclic AMP and cyclic GMP was increased in response to LPS, but production of cyclic AMP only was evident prior to the increased permeation of the cell monolayer. This observation suggests that the increased BBB permeability within the cerebral microvascular endothelium during bacterial meningitis occurs via a cyclic AMP-dependent process.
In contrast, other investigators, utilizing primary cultures of bovine brain microvascular endothelial cells (102) (131) . This last possibility has been investigated in patients and in animal models of meningitis. Leukocyte proteases have been shown to degrade functional complement components (e.g., C3b) in CSF from patients with meningococcal meningitis, with the formation of nonopsonic products (e.g., C3d) (179).
In the experimental rabbit model of pneumococcal meningitis, the intracisternal inoculation of phenylmethylsulfonyl fluoride, a nonspecific protease inhibitor, led to a decline in pneumococcal concentrations in CSF compared with those of saline-inoculated controls (131) . Therefore, during bacterial meningitis, complement components crossing the BBB may be degraded by leukocyte proteases, resulting in inefficient opsonic activity at the site of infection similar to mechanisms postulated to occur in the pleural space during the development of an empyema.
CSF Antibody
Immunoglobulin concentrations are also low in normal CSF, with an average blood/CSF ratio of IgG of about 800:1. Immunoglobulin concentrations in CSF increase during bacterial meningitis but remain low compared with simultaneous concentrations in serum, and IgG does not appear in the CSF until late in the course of disease (142, 179) . An experimental rabbit model of pneumococcal meningitis has been utilized to study the importance of antibodies in host defense against bacterial meningitis. Intracisternal inoculation of type-specific antibodies against S. pneumoniae decreased pneumococcal concentrations in CSF, but at a much slower rate than did treatment with appropriate bactericidal antibiotics (131) . The systemic administration of type-specific monoclonal antibodies has been examined in the experimental rabbit model. Intravenous injection of a bactericidal monoclonal antibody against the polyribosyl-ribitol phosphate of H. influenzae type b produced high concentrations of antibody in serum, but there was poor BBB penetration (c5.5%), even in the presence of meningeal inflammation (47) . These results suggested that systemic administration of type-specific antibodies alone is suboptimal. The pioneering work of Flexner (42) , who demonstrated that systemic and intrathecal administration of antimeningococcal antiserum raised in horses was effective in reducing the mortality rate in meningococcal meningitis from approximately 80 to 30%, suggests that combined sites of administration may be useful. It remains to be determined, however, whether the intrathecal administration of antibodies may be useful in the adjunctive treatment of bacterial meningitis.
CSF Leukocytes
One of the hallmarks of bacterial meningitis is the development of a neutrophilic pleocytosis within the CSF, although the precise mechanisms of leukocyte traversal across the BBB remain to be defined (52, 184) . In an experimental animal model of pneumococcal meningitis, the complement component C5a has been suggested as one chemotactic substance in CSF (35, 96, 158) , with chemotactic activity appearing 2 to 4 h before neutrophil influx into the CSF. The precise role of C5a as a chemotactic substance has recently been examined in the experimental rabbit model, in which the intracistemal inoculation of C5a caused a rapid early influx of leukocytes into CSF 1 h after inoculation (60) . This response was attenuated by coadministration of CSa with prostaglandin E2 (PGE2) in a dose-dependent manner, suggesting a direct anti-inflammatory action of PGE2 on CSagenerated CSF pleocytosis during bacterial meningitis. However, despite the entry of leukocytes, host defense mechanisms in CSF remain suboptimal because of the relative lack of functional opsonic and bactericidal activity. Therefore, phagocytosis is inefficient at this protected site, leading to huge concentrations of bacteria in the CSF during meningitis (36, 37) .
There is controversy over the precise role of neutrophils in host defense within the CNS during bacterial meningitis. In experimental animal models, low concentrations of leukocytes in CSF have generally been associated with increased mortality rates (46, 134) . Although a study of dogs with pneumococcal meningitis revealed that leukopenic animals had a higher survival rate than animals with normal peripheral leukocyte counts (62 versus 47 h) (104), the small number of animals studied precluded statistical analysis. In an experimental rabbit model of pneumococcal meningitis, the parameters of bacterial growth rate; final concentrations of bacteria in CSF; and concentrations of protein, glucose, and lactate in CSF were no different in animals rendered leukopenic by the prior intravenous inoculation of nitrogen mustard than in nonleukopenic animals. However, the resultant bacteremia was about 100-fold greater in leukopenic animals (34), suggesting that neutrophils either prevented traversal of pneumococci from CSF to blood or enhanced neutrophil-mediated bacterial elimination from the bloodstream at extraneural sites.
The precise pathway by which neutrophils enter the subarachnoid space remains unknown. Adherence of neutrophils to vascular endothelial cells is a likely prerequisite for traversal into the CSF. Pretreatment of endothelial cells with cytokines induces formation of specific adhesion molecules such as endothelial leukocyte adhesion molecule 1 (16) . Neutrophil adherence to vascular endothelial cells is enhanced by pretreatment of the endothelial cells with LPS (137) or with inflammatory cytokines such as IL-1 and TNF (15, 137, 165) . Similar mechanisms may also enhance neutrophil binding to cerebral vascular endothelium (11) . A recent study of an experimental rabbit model has demonstrated that the intravenous inoculation of a monoclonal antibody (IB4) against the CD18 family of receptors on leukocytes blocked the accumulation of leukocytes in the subarachnoid space despite intracisternal challenge with H. influenzae type b, N. meningitidis, pneumococcal cell wall, or LPS (170) . The monoclonal antibody also attenuated a parameter of BBB permeability (i.e., increased protein concentrations in the CSF). Furthermore, development of cerebral edema and death were prevented in monoclonal antibody-treated animals challenged with lethal doses of S. pneumoniae. Penetration of antibiotics into CSF, bacterial concentrations in CSF, and bactericidal response to ampicillin therapy were not affected by monoclonal antibody administration, although the animals exhibited a delay in the onset of bacteremia and there was an attenuated CSF inflammatory response after ampicillin-induced bacterial killing. These results suggest that systemic inoculation of monoclonal antibodies directed at leukocyte-endothelium interactions can block leukocyte-mediated damage within the CNS during bacterial meningitis. INDUCTION antibody directed against epitopes on the oligosaccharide portion of the LPS molecule did not reduce the inflammatory potential of the LPS. Similar results were observed in an experimental rat model following the intracisternal inoculation of purified LPS, with the maximal amount of inflammation observed 8 h after inoculation of a 20-ng dose (Fig. 3 ) (183) . In addition, the intracisternal inoculation of outer membrane vesicles from H. influenzae type b induced meningeal inflammation in both rabbits and rats in a dose-and time-dependent manner (92, 182) nificantly reduced concentrations of PGE2 and IL-lp in CSF and improved several indices of meningeal inflammation. Inoculation of purified rabbit TNF-a or human recombinant IL-1B into the CSF of rabbits also produced significant CSF inflammation (117) . Simultaneous administration of lower doses of each cytokine resulted in an apparent synergistic inflammatory response that was manifested by a more rapid and significantly increased influx of leukocytes into CSF than occurred with administration of each cytokine alone. In contrast, in an experimental rabbit model of pneumococcal meningitis, CSF leukocytosis, BBB permeability, and brain edema were induced by intracisternal inoculation of human recombinant TNF-a, macrophage inflammatory proteins 1 and 2, and IL-la but not by intracisternal inoculation with IL-lp (127) . Antibodies homologous to each mediator inhibited leukocytosis and brain edema. In rabbits treated with a monoclonal antibody to CD18 to render neutrophil-endothelial cell interactions dysfunctional, each cytokine lost the ability to cause leukocytosis and brain edema. Therefore, these cytokines have multiple complex and interrelated activities in the CNS that contribute to tissue damage during pneumococcal meningitis.
These findings have implications with regard to outcomes in patients with bacterial meningitis. Outcome from meningitis due to gram-negative bacilli has been correlated with persistence of organisms and higher concentrations of endotoxin in CSF (as detected by the Limulus lysate assay) (73) . A study of children with H. influenzae meningitis documented that treatment with ceftriaxone induced a marked increase in concentrations of free LPS in CSF within 2 to 6 h ( Table 2 ) that correlated with the Herson-Todd severity score and the number of febrile hospital days (5) . These data suggest that early release of "free" LPS (i.e., LPS not present in outer membranes of viable organisms) after antimicrobial therapy enhances the host subarachnoid space inflammatory response. The degree of elevated concentrations of IL-1lB in CSF also correlated significantly with outcome from neonatal gram-negative bacillary meningitis in children (88) . In another study of infants and children predominantly with H. influenzae type b meningitis, patients with IL-113 concentrations in CSF of .500 pg/ml were more likely to develop neurologic sequelae (87) . Although elevated concentrations of TNF in CSF were observed in 50 to 75% of patients with bacterial meningitis, there was no correlation between concentrations of TNF in CSF and outcome. The roles of other inflammatory cytokines in the induction of subarachnoid space inflammation are less clear. Elevated concentrations of platelet-activating factor in CSF have been demonstrated in children with H. influenzae meningitis (6) and correlated with bacterial density and with LPS and TNF-a concentrations in CSF. These increased concentrations of TNF-a and platelet-activating factor were associated with severity of disease. Increased concentrations of IL-6, occurring after release of TNF-ot and before neutrophilic infiltration into CSF (174) , have also been observed in patients with bacterial meningitis (58, 123, 175) . These experimental and clinical studies strongly suggest that release of inflammatory mediators into the CSF during bacterial meningitis is responsible for induction of a marked subarachnoid space inflammatory response and may possibly correlate with morbidity and mortality from this disorder.
The source of these inflammatory cytokines within the CSF of patients with bacterial meningitis is unclear. LPS stimulation of astrocytes and microglia in vitro leads to release of various cytokines (43) , and vascular endothelial cells in culture produce IL-1 in response to stimulation with either LPS or TNF (69, 78, 94) . One study utilizing purified preparations of cerebral microvascular endothelial cells from rats has demonstrated that these cells release IL-6 in vitro in response to LPS stimulation (160) . Further studies, however, are warranted to address these issues as they pertain to the patient with bacterial meningitis.
INCREASED INTRACRANIAL PRESSURE
The major element that contributes to an increase in intracranial pressure during bacterial meningitis is the development of cerebral edema, which may be vasogenic, cytotoxic, and/or interstitial in origin and may result in lifethreatening cerebral herniation and other complications (26, 40, 41, 57, 98) . Vasogenic cerebral edema is principally a consequence of increased BBB permeability (see above). Cytotoxic cerebral edema results from swelling of the cellular elements of the brain, most likely due, in bacterial meningitis, to release of toxic factors from neutrophils or bacteria or both. Secretion of antidiuretic hormone also contributes to the pathogenesis of cytotoxic edema, with resultant hypotonicity of extracellular fluid and increased permeability of the brain to water (62) . Interstitial edema reflects obstruction of flow in normal CSF pathways (e.g., from the subarachnoid space to blood), as in hydrocephalus.
In an experimental rabbit model of pneumococcal or E. coli-caused meningitis, the CSF outflow resistance, defined (and quantified) as factors that inhibit the flow of CSF from the subarachnoid space to the major dural sinuses, was markedly elevated (133); these alterations remained for as long as 2 weeks despite rapid CSF sterilization with penicillin therapy. An increase in the outflow resistance to CSF movement may cause interstitial brain edema and/or the resultant hydrocephalus during bacterial meningitis.
Subsequent studies have examined these concepts in more detail by measuring the water content of the brain (indicative of cerebral edema if elevated), concentrations of lactate in CSF, and CSF pressure in animals with pneumococcal meningitis (154) . All three parameters were elevated in infected animals. Treatment with ampicillin sterilized the CSF rapidly and normalized the water content of the brain VOL. 6, 1993 on October 27, 2017 by guest http://cmr.asm.org/ Downloaded from and intracranial pressure within 24 h, but the concentration of lactate in the CSF remained elevated. The bacterial cell components responsible for the production of brain edema were studied in an experimental model of E. coli-caused meningitis (155) . Treatment with cefotaxime but not chloramphenicol induced a marked rise in concentrations of endotoxin in the CSF that were associated with an increase in the water content of the brain. These effects were neutralized by either polymyxin B or a monoclonal antibody against lipid A, indicating that increased concentrations of endotoxin in CSF may be associated with brain edema. The putative role of the leukocyte in these processes was recently examined in an experimental meningitis model (152) . In sterile meningitis induced by the intracisternal inoculation of N-formylmethionylleucylphenylalanine (fMLP), a chemotactic peptide, both high (10-' M) and low (10-5 M) doses induced a CSF pleocytosis, although only high doses produced an increase in the water content of the brain; intracranial pressure and the concentrations of lactate and protein in the CSF were unaltered. No increase in the water content of the brain was observed in neutropenic animals. When high doses of N-formylmethionylleucylphenylalanine were injected during the course of pneumococcal meningitis in rabbits, the results were similar, suggesting that neutrophils contributed to cerebral edema if adequately stimulated. The parameters of increased intracranial pressure and increased concentrations of lactate and protein in the CSF seemed unrelated to the presence of neutrophils. This area remains controversial, however, because neutrophils are required for the increased BBB permeability seen in response to intracisternal injection of bacterial products and inflammatory mediators (112, 183) . Additional studies are needed to more precisely define the role of the neutrophil within the CNS in the pathophysiology of bacterial meningitis.
Variability among bacterial strains may also be an important determinant in the production of brain edema. A recent study found that intracisternal injection of three different pneumococcal isolates resulted in pronounced differences in the pathophysiologic profiles 24 h after challenge (153) . Following intracisternal inoculation of pneumococcal cell wall fragments, the chemical composition of the fragments, specifically the degree of teichoication, was found to influence the induction of brain edema during bacterial meningitis. Spontaneous release of cell wall is reduced for certain pneumococcal strains and may thus limit their inflammatory potential. Further work is needed, however, to determine whether these differences affect the clinical expression of disease.
CEREBRAL VASCULITIS Bacterial meningitis exerts profound effects on blood vessels coursing through the subarachnoid space (116) . The resulting vasculitis leads to narrowing and/or thrombosis of cerebral blood vessels and the propensity for ischemia and/or infarction of underlying brain. Arteriography in children with bacterial meningitis uniformly demonstrates leakage of contrast material or other vascular abnormalities in the subarachnoid space, although these changes reverted to normal following successful antibiotic therapy. Severe neurologic complications (e.g., hemiparesis and quadriparesis) with permanent sequelae may result from involvement of the large arteries at the base of the brain (59) . Vasospasm may also occur secondary to release of humoral factors elaborated within the CSF or blood vessel wall and may subsequently lead to vasodilatation or organic stenosis or both later in the course of disease (185) . Phlebitis of the major cortical draining vessels or dural sinuses or both may result in thrombosis with secondary brain infarction, focal neurologic deficits, and prominent seizure activity.
ALTERATIONS IN CEREBRAL BLOOD FLOW
In combination with increased intracranial pressure, cerebral vasculitis may result in altered cerebral blood flow in patients with bacterial meningitis. In the infant rhesus monkey model of H. influenzae meningitis, cerebral blood flow (measured by an autoradiographic technique utilizing [14C]antipyrine) was lower in certain areas of the cortex (postcentral, temporal, and occipital areas) than in the hypothalamus and midbrain while the brain stem was hyperperfused, suggesting that one of the initial physiologic changes in H. influenzae meningitis is cerebral cortical hypoperfusion with resultant relative cerebral anoxia (141) . A recent report has demonstrated that cerebrovascular autoregulation is lost in experimental bacterial meningitis (171) . Cerebral blood flow was increased when systemic blood pressure was raised and decreased when blood pressure was lowered, indicating that flow was pressure passive. Similar changes were observed in intracranial pressure; increased blood flow led to increased intracranial pressure. Furthermore, in an experimental rat model of meningitis (105) , an increase in cerebral blood flow was observed within the first few hours of intracisternal inoculation of either live pneumococci or pneumococcal cell wall fragments. These results suggested that maintenance of adequate intravascular volume status and minimization of stimuli that increase systemic blood pressure may be important in the treatment of bacterial meningitis and of potentially practical clinical relevance. Measurement of cerebral blood flow (by the xenon-133 intra-arterial injection method) in an earlier study of patients with bacterial meningitis revealed a 30 to 40% reduction in average total blood flow in five patients with pneumococcal meningitis (mean age, 54 years) but not in five patients with meningococcal meningitis (mean age, 20 years) (165) . An inverse relationship between cerebral blood flow velocity and intracranial pressure has been seen in infants with bacterial meningitis (76) . Among eight patients, these alterations were detected only in the four older infants (ages, 3 to 10 months) and not in the four neonates (ages, 5 to 30 days), in whom no changes in cerebral blood flow velocity were observed.
A subsequent study that measured total and regional cerebral blood flow by stable xenon computed tomography in 20 children seriously ill with bacterial meningitis revealed a global decrease in cerebral blood flow and even more regional variability (7) . Autoregulation of cerebral blood flow was preserved in the patients studied, although hyperventilation reduced cerebral blood flow below the ischemic threshold, raising important concerns about the routine use of hyperventilation in the management of increased intracranial pressure in patients with bacterial meningitis. Some authors have suggested that in infants and children with bacterial meningitis and initially normal computed tomography or magnetic resonance imaging scans, the chance that cerebral blood flow would be reduced to ischemic levels is unlikely, and in this situation hyperventilation may safely reduce elevated intracranial pressure for the first 24 to 48 h before its effect diminishes (8) (173) in which animals given a lower fluid regimen (50 ml/kg per 24 h) of normal saline had lower mean arterial blood pressure, lower cerebral blood flow, and higher concentrations of lactate in the CSF compared with animals that received a higher fluid regimen (150 ml/kg per 24 h). These results suggest that intravascular volume status may be a critical factor in determination of cerebral blood flow and, therefore, the degree of cerebral ischemia in meningitis.
ADJUNCTIVE THERAPEUTIC STRATEGIES
Experimental Studies Because of the information supporting subarachnoid space inflammation as a major factor contributing to morbidity and mortality from bacterial meningitis, several studies in experimental animal models have examined whether attenuation of this inflammatory response might be beneficial. As stated above, the generation of pneumococcal cell wall components after treatment with bacteriolytic antibiotics in the experimental rabbit model may contribute to an increased inflammatory response within the subarachnoid space (168, 169) . This CSF inflammatory response was reduced by agents known to exert their effects by inhibition of the cyclooxygenase pathway of arachidonic acid metabolism (Table 3 ) (167) . Treatment with methylprednisolone or oxindanac in addition to antimicrobial agents was particularly effective in decreasing pneumococcal cell wall-induced inflammation, whereas another inhibitor, diclofenac sodium, was effective only when administered 5 and 7 h after inoculation of bacteria into CSF, but did not produce an inhibitory response 24 h after challenge with cell wall. An inhibitor of the lipoxygenase pathway, nordihydroguaiaretic acid, was ineffective in preventing cell wall-induced inflammation. Similar results were observed with these adjunctive agents after intracisternal challenge with live pneumococci. There was a correlation between the concentrations of the arachidonic acid metabolite PGE2 and of leukocytes in the CSF after intracisternal challenge with either live pneumococci or pneumococcal cell walls, and inhibition of the cyclooxygenase pathway reduced CSF inflammation and the concentration of PGE2 in the CSF. Administration of the nonsteroidal anti-inflammatory agent indomethacin also led to a decrease in both the water content of the brain and concentrations of PGE2 during experimental rabbit pneumococcal meningitis, although there was no reduction in intracranial pressure (172) . In addition, an anti-inflammatory agent (dexamethasone or oxindanac) lessened the massive influx of serum albumin and other proteins of high and low molecular masses into the CSF during the early phases of experimental pneumococcal meningitis (61) . Ampicillin given alone or in combination with indomethacin was ineffective in preventing this influx, and the abnormal protein profile in the CSF persisted for up to 30 days after the initiation of the experimental infection.
Several corticosteroid agents have been evaluated in experimental animal models of bacterial meningitis. Early studies revealed a significant reduction in the mass of leukocytes within the meninges of rabbits with pneumococcal meningitis following methylprednisolone administration compared with concentrations in infected controls (97) ; chemotactic activity, chemotactic response, and phagocytosis in CSF were, however, not altered by methylprednisolone treatment, although there was an attenuation of rabbit neutrophil adherence to a nylon fiber column. CSF outflow resistance (defined as factors that inhibit the flow of CSF from the subarachnoid space to the major dural sinuses and quantified following infusion of mock CSF into the subarachnoid space) was also reduced by methylprednisolone therapy and to a greater extent than in untreated or penicillin-treated rabbits with pneumococcal meningitis (133) . The reduction in resistance was apparent within 4 h of the second injection of methylprednisolone (at a dose of 30 mg/kg of body weight intramuscularly 16 and 20 h following intracistemal inoculation); a rebound increase in CSF outflow resistance was not seen after corticosteroid therapy was discontinued.
The effects of methylprednisolone or dexamethasone on water content of the brain, CSF pressure, and lactate con-VOL. 6, 1993 on October 27, 2017 by guest http://cmr.asm.org/ Downloaded from (132) .
The subarachnoid space inflammatory response may contribute to the pathogenesis of hearing loss in bacterial meningitis, which is due in part to the development of labyrinthritis following spread of infection to the inner ear. The infant rat model has been utilized to determine the influence of corticosteroid administration on the inflammatory reaction in the cochleas of infected animals (63) . Infant rats were inoculated intraperitoneally with H. influenzae type b, and 24 h later they were treated with ampicillin or ampicillin plus dexamethasone. At 48 h, concentrations of leukocytes in CSF were significantly lower in the dexamethasone group than in the ampicillin-alone group, although no histologic differences in the degree of cochlear inflammation were noted between groups. The extent of cochlear inflammation was minimal only in the ampicillin group, however.
Pentoxifylline, a phosphodiesterase inhibitor that decreases endotoxin-induced TNF-a production and attenuates the inflammatory action of IL-1 and TNF on leukocyte function (147) , has also been examined in the experimental rabbit model of H. influenzae type b meningitis (125) .
Administration of pentoxifylline 20 min before intracisternal challenge with H. influenzae type b LPS significantly reduced concentrations of leukocytes, protein, and lactate in CSF. Peak concentrations of TNF in CSF were reduced by more than one-third in pentoxifylline-treated animals, although this reduction was not statistically significant and was unlikely to be solely responsible for the marked modulation of meningeal inflammation. Dexamethasone was superior to pentoxifylline in modulation of these inflammatory changes in CSF, and no appreciable synergism was observed when dexamethasone and pentoxifylline were used together. Recent dual therapy with agents directed against the CSF production of cytokines and recruitment of leukocytes into the subarachnoid space may be associated with improved outcome in bacterial meningitis.
Clinical Trials
Taken together, the experimental studies described above indicate that adjunctive dexamethasone therapy diminishes the CSF inflammatory response and the subsequent pathophysiologic consequences of this inflammation, specifically, elevated water content in the brain and elevated CSF pressure. On the basis of these observations, several trials were undertaken to examine the effects of adjunctive corticosteroids on outcomes in patients with bacterial meningitis. Early clinical trials performed in the 1960s failed to show any benefit for adjunctive corticosteroids (either methylprednisolone or dexamethasone) (12, 31 but not TNF-cx in CSF were significantly lower 18 to 36 h later in patients given adjunctive dexamethasone. However, these findings were significant only in patients with meningitis caused by H. influenzae type b, and the benefits in terms of morbidity (sensorineural hearing loss) were statistically significant only in patients receiving cefuroxime and not in those receiving ceftriaxone. The latter point is important, because cefuroxime has recently been shown to be inferior to ceftriaxone in a randomized prospective study of the therapy of childhood bacterial meningitis (129) . In addition, four patients who received adjunctive dexamethasone developed gastrointestinal hemorrhage, and two of these patients required blood transfusions.
A second study, from Egypt, of children and adults with bacterial meningitis demonstrated a significant reduction in mortality rate and overall neurologic sequelae in patients with pneumococcal meningitis who received adjunctive dexamethasone therapy concomitant with antibiotics (ampicillin plus chloramphenicol) (48) . However, no significant differences between groups in time to afebrility or improvement in CSF parameters were observed; furthermore, the antibiotics were given intramuscularly, there was no documentation of possible adverse effects, and an extraordinarily high percentage of patients presented in a comatose state. In fact, most patients (370 of 429) had received inadequate therapy for the 3 to 5 days prior to hospitalization. There were no differences between the two groups in mortality rate or rate of hearing impairment for patients with meningococcal or H. influenzae meningitis, but children with H. influenzae meningitis were too young to be tested audiometrically.
In a third recently published trial centered in Costa Rica (99) , infants and children with bacterial meningitis were randomized in a placebo-controlled, double-blind fashion to receive cefotaxime with or without adjunctive dexamethasone therapy; in this study, the dexamethasone was administered 15 to 20 min before the first dose of cefotaxime in an effort to attenuate the CSF inflammatory response associated with administration of bacteriolytic antibiotics. Twelve hours after treatment was begun, meningeal inflammation and concentrations of TNF-a and platelet-activating factor in CSF had decreased more rapidly in dexamethasonetreated patients. In addition, by 24 h, the clinical conditions and mean prognostic scores were significantly better among patients receiving adjunctive dexamethasone therapy. When the patients were monitored for a mean of 15 months, those who had received adjunctive dexamethasone had a significantly decreased incidence of one or more neurologic sequelae, although reduction of audiologic impairment was VOL. 6, 1993 on October 27, 2017 by guest http://cmr.asm.org/ Downloaded from only a trend. Overall mortality was not reduced in the dexamethasone group.
Despite the studies described above, controversy regarding the routine use of adjunctive dexamethasone therapy in all patients with bacterial meningitis remains (75, 165) . The data support the use of adjunctive dexamethasone in infants and children with bacterial meningitis caused by H. influenzae type b. Routine use of dexamethasone therapy for adults, however, cannot be presently recommended, pending results of ongoing studies. If dexamethasone is used, the timing of administration is crucial. Administration before or with antibiotics is optimal for attenuating the subarachnoid space inflammatory response. Patients receiving such therapy also need careful monitoring (in addition to the usual routine for critically ill patients) for the possibility of gastrointestinal hemorrhage. Future studies of the pathogenesis and pathophysiology of bacterial meningitis should lead to the development of other adjunctive treatment strategies that may improve the outcome of this disorder. 
